Clinical improvement of gingival hyperplasia with cholorhexidine , persica and powered brush in fixed orthodontic cases

Clinical improvement of gingival hyperplasia with mouthwashes cholorhexidine vs persica and powered brush in fixed orthodontic cases

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201202209086N1

Enrollment

Registered

2012-04-30

Start date

2012-04-30

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gingival enlargment. Gingival enlargement

Interventions

Intervention 1: Patient recieves toothbrush , toothpaste(control) , and oral hygiene instruction and requested to do instructions for 2 weeks. Intervention 2: Patient recieves powerde toothbrush , too

Treatment - Drugs

Patient recieves toothbrush , toothpaste(control) , and oral hygiene instruction and requested to do instructions for 2 weeks.

Patient recieves powerde toothbrush , toothpaste , and oral hygiene instruction and requested to do instructions for 2 weeks.

Patient recieves toothbrush , toothpaste , and oral hygiene instruction and persica mouthwash requested to do instructions according to manufacture for 2 weeks.

Patient recieves toothbrush , toothpaste , and oral hygiene instruction and cholorhexidine mouthwash requested to do instructions according to manufacture for 2 weeks.

Eligibility

Sex/Gender

All

Age

12 Years to 30 Years

Inclusion criteria

Inclusion criteria: Inclusion :under fixed orthodontic treatment , minimum 2 teeth with gingival enlargement and inflammation. Exclusion :history of anticonvalsant drugs , history of antibiotic therapy during last 6 months , history of recieving antibacterial mouthwashes during last 6 month , presence of calcolous or bonding agent excess.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Bleeding on Probing(BOP). Timepoint: Start at case selection phase , 2 weeks after treatment protocols. Method of measurement: According to indices descriptions using periodontal probs.;Plaque index. Timepoint: Start at case selection phase , 2 weeks after treatment protocols. Method of measurement: According to indices descriptions using periodontal probs.;Gingival hyperplastic index. Timepoint: Start at case selection phase , 2 weeks after treatment protocols. Method of measurement: According to indices descriptions using periodontal probs.;Gingival index. Timepoint: Start at case selection phase , 2 weeks after treatment protocols. Method of measurement: According to indices descriptions using periodontal probs.	—

Measure

Time frame

Bleeding on Probing(BOP). Timepoint: Start at case selection phase , 2 weeks after treatment protocols. Method of measurement: According to indices descriptions using periodontal probs.;Plaque index. Timepoint: Start at case selection phase , 2 weeks after treatment protocols. Method of measurement: According to indices descriptions using periodontal probs.;Gingival hyperplastic index. Timepoint: Start at case selection phase , 2 weeks after treatment protocols. Method of measurement: According to indices descriptions using periodontal probs.;Gingival index. Timepoint: Start at case selection phase , 2 weeks after treatment protocols. Method of measurement: According to indices descriptions using periodontal probs.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNasrin Farhadian

Dental faculty, Hamadan University of Medical Sciences

nasrinne@yahoo.com+98 81 1836 4017

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026